Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2013-09-10 16:00:37 |
Versijas komentārs | |
Teksts |
Olainfarm will Hold Investor Conference Webinar about Recent Developments
„Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its investor conference webinar
scheduled on September 10, 2013 at 16:00
(EET).
Webinar
will be hosted by the member of the management board Salvis Lapiņš.
The presentation will be in English.
During
the webinar topics in relation to AS “Olainfarm” expansion plans
and analysis of company’s recent activities and financial results
will be discussed.
How to
join the webinar?
During
the webinar the enclosed presentation will be
presented.
A/s
OlainFarm is one of the biggest pharmaceutical companies in Latvia
with 40 years of experience in production of medication and
chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 30 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia.
Information
prepared by:
|
Pielikumi |